Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shangkun Zhang

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
International Journal of Biological Macromolecules|December 6, 2021
Lignin-based fluorescence-switchable graphene quantum dots for Fe<sup>3+</sup> and ascorbic acid detectionLingyan Zhu, Dongbing Li, Heng Lu, et al.
Organic Letters|May 14, 2024
Rh-Catalyzed α-Arylation of Cyclic 1,3-Dicarbonyls with Benzocyclobutenols Enabled by a Cyclic Iodonium Ylide StrategyBorong Su, Zhenwei Zhang, Shangkun Zhang, et al.
Optics Express|June 11, 2024
Superconducting nanowire single-photon detector with polarization insensitivity, ultrafast response, and high efficiencyMin Gu, Shangkun Zhang, Xianghao Wang, et al.
Journal of Hazardous Materials|April 14, 2023
Highly distributed amorphous copper catalyst for efficient ammonia electrosynthesis from nitrateZhen Shen, Yingsong Yu, Zhiwei Zhao, et al.
Frontiers of Medicine|February 8, 2024
EBV-associated lymphoproliferative disease post-CAR-T cell therapyShiyuan Zhang, Xiaoxi Zhou, Shangkun Zhang, et al.
Optics Express|March 18, 2026
Single-shot dual-modality quantitative phase and polarization microscopyShangkun Zhang, Hu Liu, Wei Zhou, et al.
Journal of Hematology & Oncology|July 3, 2026
Dual-modular-nanobody CAR-T cell technical platform against the solid tumor microenvironmentYangzi Li, Xuan Wang, Shangkun Zhang, et al.
Blood Cancer Journal|October 19, 2021
Viral infection/reactivation during long-term follow-up in multiple myeloma patients with anti-BCMA CAR therapyDi Wang, Xia Mao, Yimei Que, et al.
Experimental Hematology & Oncology|October 17, 2022
Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30<sup>+</sup> lymphomaPeiling Zhang, Xiuxiu Yang, Yang Cao, et al.
Clinical and Translational Medicine|September 30, 2020
Long-term outcomes of relapsed/refractory double-hit lymphoma (r/r DHL) treated with CD19/22 CAR T-cell cocktail therapyJia Wei, Zekai Mao, Na Wang, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
International Journal of Biological Macromolecules|December 6, 2021
Lignin-based fluorescence-switchable graphene quantum dots for Fe<sup>3+</sup> and ascorbic acid detectionLingyan Zhu, Dongbing Li, Heng Lu, et al.
Organic Letters|May 14, 2024
Rh-Catalyzed α-Arylation of Cyclic 1,3-Dicarbonyls with Benzocyclobutenols Enabled by a Cyclic Iodonium Ylide StrategyBorong Su, Zhenwei Zhang, Shangkun Zhang, et al.
Optics Express|June 11, 2024
Superconducting nanowire single-photon detector with polarization insensitivity, ultrafast response, and high efficiencyMin Gu, Shangkun Zhang, Xianghao Wang, et al.
Journal of Hazardous Materials|April 14, 2023
Highly distributed amorphous copper catalyst for efficient ammonia electrosynthesis from nitrateZhen Shen, Yingsong Yu, Zhiwei Zhao, et al.
Frontiers of Medicine|February 8, 2024
EBV-associated lymphoproliferative disease post-CAR-T cell therapyShiyuan Zhang, Xiaoxi Zhou, Shangkun Zhang, et al.
Optics Express|March 18, 2026
Single-shot dual-modality quantitative phase and polarization microscopyShangkun Zhang, Hu Liu, Wei Zhou, et al.
Journal of Hematology & Oncology|July 3, 2026
Dual-modular-nanobody CAR-T cell technical platform against the solid tumor microenvironmentYangzi Li, Xuan Wang, Shangkun Zhang, et al.
Blood Cancer Journal|October 19, 2021
Viral infection/reactivation during long-term follow-up in multiple myeloma patients with anti-BCMA CAR therapyDi Wang, Xia Mao, Yimei Que, et al.
Experimental Hematology & Oncology|October 17, 2022
Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30<sup>+</sup> lymphomaPeiling Zhang, Xiuxiu Yang, Yang Cao, et al.
Clinical and Translational Medicine|September 30, 2020
Long-term outcomes of relapsed/refractory double-hit lymphoma (r/r DHL) treated with CD19/22 CAR T-cell cocktail therapyJia Wei, Zekai Mao, Na Wang, et al.
Pageof 2